NCT06876727View on ClinicalTrials.gov

Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair

CompletedOBSERVATIONAL
Enrollment

8,325

Participants

Timeline

Start Date

January 1, 2003

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Abdominal Aortic Aneurysms (AAA)Endovascular Aneurysm Repair (EVAR)
All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT06876727 - Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair | Biotech Hunter | Biotech Hunter